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Toxoplasma Does Not Secrete the
GRA16 and GRA24 Effectors Beyond
the Parasitophorous Vacuole
Membrane of Tissue Cysts
Shruthi Krishnamurthy and Jeroen P. J. Saeij*
Department of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis, Davis,
CA, United States
After invasion, Toxoplasma resides in a parasitophorous vacuole (PV) that is surrounded
by the PV membrane (PVM). Once inside the PV, tachyzoites secrete dense granule
proteins (GRAs) of which some, such as GRA16 and GRA24, are transported beyond the
PVM likely via a putative translocon. However, once tachyzoites convert into bradyzoites
within cysts, it is not known if secreted GRAs can traffic beyond the cyst wall membrane.
We used the tetracycline inducible system to drive expression of HA epitope tagged
GRA16 and GRA24 after inducing stage conversion and show that these proteins are not
secreted beyond the cyst wall membrane. This suggests that secretion of GRA beyond
the PVM is not important for the tissue cyst stage of Toxoplasma.
Keywords: Toxoplasma gondii, secreted effectors, tissue cyst wall, tetracycline inducible expression, GRA16,
GRA24
INTRODUCTION
Toxoplasma gondii, which belongs to the phylum Apicomplexa, is an obligate intracellular
parasite that can cause disease in immuno-compromised patients and fetuses (Montoya and
Liesenfeld, 2004; Weiss and Dubey, 2009). It is the causative agent of toxoplasmosis, the 2nd
most common cause of food-borne illness in the USA (Jones and Dubey, 2012). Infectious
tissue cysts are present in brain and muscles of many warm-blooded chronically infected hosts
(Kim and Weiss, 2004). Infected cats, which are the definitive hosts, shed infectious oocysts in
their feces contaminating food and water sources. Infection is initiated by ingestion of either
tissue cysts containing the bradyzoite life-cycle stage or oocysts (Dubey, 1998). Upon stage
conversion into tachyzoites and invasion of a host cell, Toxoplasma forms a parasitophorous
vacuole (PV) that is surrounded by the PVmembrane (PVM) (Black and Boothroyd, 2000). During
invasion, Toxoplasma secretes effector proteins from rhoptries (ROPs), which mediate invasion,
inhibition of host restriction factors, and modulation of host signaling pathways (Dubremetz,
2007; Boothroyd and Dubremetz, 2008; Hakimi et al., 2017). Once inside the PV, proteins from
the dense granule secretory organelles (GRAs) are secreted onto, and beyond the PVM into the
host cell cytoplasm (Hakimi and Bougdour, 2015; Hakimi et al., 2017). Three putative translocon
proteins: Myc-regulation 1 (MYR1) along with MYR2 and MYR3 determine transport of GRA16
and GRA24 across the PVM into the host cell cytoplasm after which they traffic to the host cell
nucleus (Franco et al., 2016; Marino et al., 2018). In addition to these putative translocon proteins,
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an aspartyl protease, ASP5 cleaves many secreted GRA proteins
at a characteristic RRLxx motif also known as the Toxoplasma
export element (TEXEL) motif which is important for their
localization and function (Coffey et al., 2015; Hammoudi et al.,
2015). Most of these effectors that have been characterized are
from the non-orally infectious tachyzoite stage. It is unclear if
bradyzoites within tissue cysts, akin to tachyzoites within the PV,
can secrete GRAs beyond the PVM as the cyst wall is built on the
inside of the PVM (Jeffers et al., 2018) and presents a potential
barrier for GRA secretion into the host cell.
GRA16, GRA24, GRA28 and IST (T. gondii inhibitor of STAT1
transcriptional activity) are secreted by tachyzoites beyond the
PVM and traffic to the host nucleus (Bougdour et al., 2013; Braun
et al., 2013; Gay et al., 2016; Nadipuram et al., 2016; Olias et al.,
2016) where they modulate host signaling pathways important
for parasite fitness. In this brief report we use the tetracycline
inducible system to induce the expression of epitope tagged
GRA16 and GRA24 after in vitro stage conversion. We observed
that anhydrotetracycline (ATc) induced GRA16-HA and GRA24-
HA are not secreted beyond the PVM and are not localized to
the host cell nucleus. Instead, they accumulate within the in vitro
tissue cysts.
MATERIALS AND METHODS
Host Cells and Parasite Strain
Human foreskin fibroblasts (HFFs) were used as host cells
and were cultured under standard conditions using Dulbecco
Modified Eagle Medium (DMEM) with 10% fetal bovine serum
(FBS) (Rosowski et al., 2011). We chose GT1 parasites expressing
tetracycline repressor (Tet-R) (Etheridge et al., 2014), a type
I strain that is capable of forming cysts during in vitro stage
conversion (Lindsay et al., 1991; Fux et al., 2007) induced by pH
8-8.2+low CO2 (Skariah et al., 2010).
Plasmid Construction
Using Gibson assembly (Gibson et al., 2009), we constructed
Tet-On plasmids with a phleomycin resistance cassette to express
GRA16-HA and GRA24-HA. The pTeton vector backbone
was amplified with the following primers which were used to
construct both the pTetONGRA16-HA SRS22A3′UTR as well as
the pTetONGRA24-HA SRS22A3UTR constructs:
vector TetON for-GCATCCACTAGTGCTCTTCAAGGTT
TTACATCCGTTGCCT
Vector TetON rev-AATTGCGCCATTTTGACGGTGACGA
AGCCACCTGAGGAAGAC
The following primers were used to amplify the pieces for
pTetONGRA16-HA SRS22A3
′
UTR Gibson assembly:
Vector GRA16 for-ACCGTCAAAATGGCGCAATTATGTAT
CGAAACCACTCAGGGATAC
Abbreviations: Tet-on, tetracycline inducible system; TetR, tetracycline repressor
protein; ATc, anhydrotetracycline; HA, hemagglutinin epitope tag; YFP, yellow
fluorescent protein; Ble, phleomycin; HFF, human foreskin fibroblast; DBA
lectin, dolichos biflorus agglutinin; IFA, indirect immunofluorescence; GRA,
dense granule proteins; ROP, rhoptry proteins; IST, T. gondii inhibitor of STAT1
transcriptional activity; PV, parasitophorous vacuole; PVM, PV membrane.
SRS22UTRGRA16 rev-AATGACAGGTTCAAGCATAATCG
GGAACGTCGTATG
GRA16HA SRS22A for-TTATGCTTGAACCTGTCATTTAC
CTCCAGTAAACATG
SRS22Avector rev-TGAAGAGCACTAGTGGATGCGTTCT
AGTGCTGTACGGAAAAGCAAC
The following primers were used to amplify the pieces for
pTetONGRA24-HA SRS22A3
′
UTR Gibson assembly:
vectorGRA24 for –ACCGTCAAAATGGCGCAATTATGCTC
CAGATGGCACGATATACCG
SRS22AUTRGRA24HA rev-AATGACAGGTTTAAGCATAA
TCGGGAACGTCGTATG
GRA24HASRS22A For-TTATGCTTAAACCTGTCATTTA
CCTCCAGTAAACATG.
Parasite Transfection and Selection
The pTetOn vectors containing GRA16-HA and GRA24-HA
were linearized using the AseI restriction enzyme. The linearized
plasmids (50 µg) were electroporated into 5 × 107 GT1tetR
parasites using the protocol described in (Gold et al., 2015).
After lysis of parasites from host cells, they were selected twice
with 50µg/ml phleomycin (Ble) and maintained in 5µg/ml Ble
(Krishnamurthy et al., 2016) after which they were cloned by
limiting dilution.
Indirect Immunofluorescence With
Tachyzoites
Coverslips with a monolayer of HFFs were infected in the
presence or absence of 2µM ATc with GT1-TetR parasites or
single clones of parasites expressing GRA16-HA and GRA24-
HA under the RPS13 promoter downstream of a Tet-O7
operator. The coverslips were fixed 16 h post infection with
3% formaldehyde and processed for IFA using rabbit anti-HA
primary (Roche) antibody followed by goat anti-rabbit Alexa-555
secondary antibody and Hoechst (Invitrogen).
In Vitro Stage Differentiation and IFA With
Tissue Cysts
HFFs were infected with a single clone of GT1-tetR parasites that
expressedGRA16-HA only in the presence of ATc. Themedia was
switched from DMEM with 10% FBS to tricine-buffered RPMI
media with pH 8.0 and put in an incubator with low CO2 after
24 h of infection (MOI = 0.1) to induce tachyzoite to bradyzoite
stage conversion. After 5 days, 2µM ATc was added and 2 days
later the coverslips were fixed with 100% cold methanol (also
eliminates YFP signal from TetR) and processed for IFA. The cyst
wall was stained with DBA-FITC (Boothroyd et al., 1997) along
with HA and Hoechst as described above.
RESULTS
To test if GRAs are secreted beyond the tissue cyst wall
membrane, we utilized the Tet-inducible system (Etheridge et al.,
2014) to express an HA-tagged copy of GRA16 or GRA24 under
the Tet operator (Tet-O) in parasites expressing Tet-R. We
could not just use GRA16-HA or GRA24-HA expressed from the
endogenous promoter because if we saw these proteins in the
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FIGURE 1 | GT1- TetR parasites express GRA16-HA and GRA24-HA only in the presence of ATc. A monolayer of HFFs were infected with single clones of GT1 Tet-R
parasites, which contained either GRA16-HA or GRA24-HA cloned in front of a TetOn promoter, in the presence or absence of ATc. Cover slips were fixed 16 h post
infection and processed for IFA as described. Tet-R is YFP tagged and GT1 Tet-R parasites do not express any proteins that are HA-epitope tagged (first panel). In the
absence of ATc, Tet-R represses the expression of GRA16-HA (A first panel) and GRA24-HA (C first panel). Repression by Tet-R is relieved only in the presence of
2µM ATc (second panel) allowing for the proper localization of GRA16-HA (A) and GRA24-HA (B) to the parasite PVM and host cell nucleus. Images are scaled to
10µm. Quantification of GRA16-HA (C) and GRA24-HA (D) secreted into the host cell nucleus only in presence of ATc was done using ImageJ. Error bars indicate
mean with SD and significance was determined by performing Student’s t-test from 3 biological replicates using Graph Pad Prism7.0 (****P < 0.0001).
host nucleus we would not know if they were secreted beyond
the PVM before the cyst wall was made (as tachyzoites) or
after the cyst wall was made (as bradyzoites). In the absence
of anhydrotetracycline (ATc), the Tet-R binds to Tet-O and
represses the transcription of either GRA16-HA or GRA24-HA
under the RPS13 promoter (Etheridge et al., 2014; Wang et al.,
2016). ATc binds TetR and relieves repression of transcription
which allows for the expression of HA-tagged GRA16 or GRA24.
Since ATc is smaller than the size-exclusion limit of the cyst wall
(Lemgruber et al., 2011), we decided to use this system to answer
our question.
To check if our constructs were able to stably express
functional GRA16 and GRA24, we first transfected them into
the RH parasite strain and observed nuclear localization of these
proteins (data not shown). After transfection of the GT1 Tet-R
expressing strain with the Tet-inducible GRA16-HA or GRA24-
HA construct and subsequent selection with phleomycin for
stable integration, we show by IFA that in tachyzoites GRA16-
HA (Figures 1A,B) and GRA24-HA (Figures 1C,D) were only
expressed in the presence of ATc.
A single parasite clone that expressed GRA16-HA or GRA24-
HA only in the presence of ATc was chosen for induction of stage
differentiation in vitro in human foreskin fibroblast (HFFs). Five
days post-switching, 2µM of ATc was added to the cultures
to induce the expression of GRA16-HA and GRA24-HA since
we observed that at least 50% of the parasites had converted to
cysts by staining the cyst wall with DBA-lectin (Boothroyd et al.,
1997) (data not shown). The parasites were fixed 48 h following
addition of ATc to allow for sufficient expression of GRA16-HA
and GRA24-HA.We performed an indirect immunofluorescence
assay (IFA) to determine the localization of GRA16 and GRA24
using anti-HA antibody as well as DBA-lectin to detect the
cyst wall. We show that in host cells containing tissue cysts,
GRA16-HA and GRA24-HA were not detected in the host cell
nucleus or beyond the tissue cyst wall membrane and that instead
they accumulated underneath the cyst wall. Almost 100% of
vacuoles we observed were DBA positive. We decided to observe
HFFs only infected with one parasite and therefore containing
only one cyst as differences in the timing of conversion could
affect the localization of GRA16 and GRA24. Out of 189 (80
for GRA16-HA and 109 for GRA24-HA from three biological
replicates) images of singly infected host cells containing
DBA positive cysts, both GRA16 and GRA24 were expressed
exclusively beneath the cyst wall only in the presence of ATc
(Figures 2A,B). We observed GRA16 and GRA24 localized to
the host cell nucleus only in multiple infected cells containing
tachyzoites, along with in vitro cysts (Supplemental Figure 1).
Thus, our results show that GRA16 and GRA24 are
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FIGURE 2 | In vitro DBA positive cysts do not secrete GRA16-HA and GRA24-HA beyond the cyst wall membrane. Stage differentiation was induced using single
clones of parasites, which contained either GRA16-HA or GRA24-HA cloned in front of a TetOn promoter, 16 h post infection of coverslips containing HFFs. ATc was
added to the monolayer containing cysts 5 days after inducing stage differentiation. Coverslips were processed for IFA with DBA-FITC to stain the cyst wall and
anti-HA antibody to track the localization of GRAs16 and 24. In the absence of ATc, GRA16-HA (A first panel) and GRA24-HA (A first panel) were not detected in
parasites. GRA16-HA (A second panel) and GRA24-HA (B second panel, inset) accumulated beneath the cyst wall only in the presence of ATc. Images are scaled to
10µm. Fluorescence intensity was measured to quantify the localization of GRA16-HA and GRA24-HA in the nucleus of infected cells, uninfected cells as well as the
tissue cysts in the presence and absence of ATc (C,D). Signal intensity was the highest and above background (uninfected cells) only for cysts in the presence of ATc.
Error bars indicate mean with SD and significance was determined using Student’s t-test from 3 biological replicates (**P < 0.05).
not secreted beyond the tissue cyst membrane into the
host cell.
DISCUSSION
We show here that GT1 parasites are able to form DBA
lectin positive in vitro cysts. We also show for the first time
that ATc is able to cross the cyst wall in vitro. Even though
bradyzoites within tissue cysts are not as metabolically active
compared to tachyzoites, it is becoming clear that they are
also not in a dormant state (Sinai et al., 2016). However,
we observed that bradyzoites do not secrete GRA16 and
GRA24 beyond the in vitro cyst wall membrane. These proteins
accumulated within the cyst wall suggesting that their role
in the host cell nucleus is not required at this stage. In
preparing for the chronic phase of their life cycle, bradyzoites
lose connectivity between themselves through the intravacuolar
network (IVN) and undergo asynchronous division (Frénal
et al., 2017). Our data indicates that the bradyzoites within
cysts also lose connectivity to host cells by not secreting GRAs,
which usually modulate host signaling pathways in tachyzoites,
beyond the PVM. Possibly bradyzoites require these proteins
during natural oral infections after excystation from tissue cysts
to establish infection in gut epithelial cells of the host. Not
secreting parasite proteins beyond the cyst wall might help
Toxoplasma to remain invisible and undetected by the host
immune response during the chronic phase of infection. This
hypothesis is in conjunction with published literature wherein
proteins from dense granules (Ferguson, 2004; Lemgruber et al.,
2011) and rhoptries (Schwarz et al., 2005) were shown to
be secreted in bradyzoites but never beyond the tissue cyst
wall. Another possibility may be that the translocon proteins
MYR1/2/3 or ASP5 are not sufficiently expressed at this stage
to effectively mediate transport of secreted GRAs beyond the
cyst wall membrane. Even though all the MYRs and ASP5
are expressed in tachyzoites, sporozoites and bradyzoites, their
expression is significantly lower in bradyzoites (Marino et al.,
2018). However, even if MYR1-3 and ASP5 are expressed, our
data indicate that the cyst wall seems to act as a barrier as
ATc- induced GRA16 and GRA24 accumulated beneath the wall
(Figure 2).
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Supplemental Figure 1 | Localization of GRA16-HA and GRA24-HA to the host
cell nucleus was observed only in multiple infected host cells containing parasites
in different stages of in vitro stage conversion. Parasites expressing GRA16-HA
(A) or GRA24-HA (B) localized the respective epitope tagged GRAs in the
parasites as well as in the host cell nucleus. Non-uniform DBA staining suggests
that the parasites were in different stages of conversion into tissue cysts. Images
are scaled to 10µm.
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